166 related articles for article (PubMed ID: 24530938)
21. Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
Johnson HC; Lafferty EI; Eggo RM; Louie K; Soldan K; Waller J; Edmunds WJ
Lancet Public Health; 2018 Jan; 3(1):e44-e51. PubMed ID: 29307388
[TBL] [Abstract][Full Text] [Related]
22. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
23. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
[TBL] [Abstract][Full Text] [Related]
24. Association between human papillomavirus vaccine status and other cervical cancer risk factors.
Bowyer HL; Dodd RH; Marlow LA; Waller J
Vaccine; 2014 Jul; 32(34):4310-6. PubMed ID: 24950359
[TBL] [Abstract][Full Text] [Related]
25. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
26. The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy.
Visioli CB; Giorgi Rossi P; Armaroli P; Iossa A; Rizzolo R; Bonelli LA; Venturino E; Carozzi FM; Bisanzi S; De Marco L; Giordano L; Camussi E; Del Mistro A; Zappa M
J Med Screen; 2023 Sep; 30(3):142-149. PubMed ID: 36999190
[TBL] [Abstract][Full Text] [Related]
27. Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study.
Martellucci CA; Morettini M; Brotherton JML; Canfell K; Manzoli L; Flacco ME; Palmer M; Rossi PG; Martellucci M; Giacomini G; D'Errico MM; Pasqualini F
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):588-594. PubMed ID: 35027435
[TBL] [Abstract][Full Text] [Related]
28. HPV vaccination: vaccine acceptance, side effects and screening intentions.
Paul-Ebhohimhen V; Huc S; Tissington H; Oates K; Stark C
Community Pract; 2010 Jun; 83(6):30-3. PubMed ID: 20586376
[TBL] [Abstract][Full Text] [Related]
29. Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol.
Thamsborg LH; Andersen B; Larsen LG; Christensen J; Johansen T; Hariri J; Christiansen S; Rygaard C; Lynge E
BMJ Open; 2018 May; 8(5):e020294. PubMed ID: 29804060
[TBL] [Abstract][Full Text] [Related]
30. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006-2016.
Ba DM; McCall-Hosenfeld JS; Ssentongo P; Chinchilli VM; Agbese E; Liu G; Leslie DL; Du P
Medicine (Baltimore); 2021 Oct; 100(41):e27457. PubMed ID: 34731120
[TBL] [Abstract][Full Text] [Related]
32. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
33. A qualitative study to assess the potential of the human papillomavirus vaccination programme to encourage under-screened mothers to attend for cervical screening.
Spencer AM; Brabin L; Roberts SA; Patnick J; Elton P; Verma A
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):119-26. PubMed ID: 26590048
[TBL] [Abstract][Full Text] [Related]
34. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
35. 'A false sense of security'? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age.
Henderson L; Clements A; Damery S; Wilkinson C; Austoker J; Wilson S;
J Med Screen; 2011; 18(1):41-5. PubMed ID: 21536816
[TBL] [Abstract][Full Text] [Related]
36. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
Cody P; Tobe K; Abe M; Elbasha EH
BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
[TBL] [Abstract][Full Text] [Related]
37. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
38. National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur.
Ezat SW; Hod R; Mustafa J; Mohd Dali AZ; Sulaiman AS; Azman A
Asian Pac J Cancer Prev; 2013; 14(5):2991-9. PubMed ID: 23803068
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.
Kim JJ; Ortendahl J; Goldie SJ
Ann Intern Med; 2009 Oct; 151(8):538-45. PubMed ID: 19841455
[TBL] [Abstract][Full Text] [Related]
40. Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.
Bhatia R; Kavanagh K; Cubie HA; Serrano I; Wennington H; Hopkins M; Pan J; Pollock KG; Palmer TJ; Cuschieri K
Int J Cancer; 2016 Jun; 138(12):2922-31. PubMed ID: 26845632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
